Merck & Co., Inc. (MRK) Applauds Colombia for First PAHO/WHO Verification of Elimination of River Blindness
7/30/2013 9:35:54 AM
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside the United States and Canada, applauds the government of Colombia whose work with the MECTIZAN® Donation Program and The Carter Center-sponsored Onchocerciasis Elimination Program for the Americas led to today’s Pan American Health Organization, the World Health Organization’s Regional Office for the Americas (PAHO/WHO), verification of Colombia as the first country in the world to eliminate the transmission of river blindness (onchocerciasis), using MECTIZAN (ivermectin). Onchocerciasis is one of the leading causes of preventable blindness worldwide.
Help employers find you! Check out all the jobs and post your resume.